1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow OPN-6602: new trials by email Literature Review of OPN-6602 trials Research Report on OPN-6602
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma OPN-6602, Dexamethasone - Relapsed Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | Recruiting | Opna Bio LLC | 130 | 2024-08-22 | 2026-05-19 |
Multiple Myeloma (1)
Opna Bio LLC (1)
United States (1)